Sartorius Stedim Biotech Stock price
Equities
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
264.3 EUR | +0.76% | -4.27% | +10.35% |
Mar. 26 | Transcript : Sartorius Stedim Biotech S.A. - Shareholder/Analyst Call | |
Mar. 12 | SARTORIUS STEDIM BIOTECH : Jefferies remains its Buy rating | ZD |
Sales 2024 * | 3B 3.24B | Sales 2025 * | 3.44B 3.71B | Capitalization | 25.72B 27.72B |
---|---|---|---|---|---|
Net income 2024 * | 359M 387M | Net income 2025 * | 497M 536M | EV / Sales 2024 * | 9.57 x |
Net Debt 2024 * | 3.03B 3.27B | Net Debt 2025 * | 2.79B 3B | EV / Sales 2025 * | 8.28 x |
P/E ratio 2024 * |
69.6
x | P/E ratio 2025 * |
50.6
x | Employees | 10,662 |
Yield 2024 * |
0.29% | Yield 2025 * |
0.39% | Free-Float | 31.97% |
Latest transcript on Sartorius Stedim Biotech
1 day | +0.76% | ||
1 week | -4.27% | ||
Current month | +3.93% | ||
1 month | +5.34% | ||
3 months | +10.26% | ||
6 months | +19.70% | ||
Current year | +10.35% |
Managers | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 19-03-25 |
Chairman | 58 | 07-06-28 | |
Chief Tech/Sci/R&D Officer | 59 | 09-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 07-06-28 |
Chairman | 58 | 07-06-28 | |
Susan Dexter
BRD | Director/Board Member | 67 | 15-04-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.42% | 18 M€ | +6.77% | - | |
0.35% | 5 M€ | +4.56% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 264.3 | +0.76% | 48,852 |
24-03-27 | 262.3 | -1.91% | 86,086 |
24-03-26 | 267.4 | -1.40% | 49,596 |
24-03-25 | 271.2 | -3.14% | 54,114 |
24-03-22 | 280 | +1.41% | 37,454 |
Real-time Euronext Paris, March 28, 2024 at 12:39 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.35% | 27.78B | |
+3.26% | 197B | |
+5.79% | 116B | |
+1.48% | 71.49B | |
+11.77% | 53.47B | |
+18.31% | 48.42B | |
+6.33% | 43.64B | |
+12.38% | 28.97B | |
+9.76% | 28.47B | |
+18.09% | 27.08B |